References
- Creese I., Sibley D. R. Receptor adaptations to centrally acting drugs, Ann. Rev. Pharmacol. Toxicol. 1981; 21: 357–391
- Reisine T. Adaptive changes in catecholamine receptors in the central nervous system. Neurosci. 1981; 6: 1471–1502
- Phelps M. E., Mazziotta J. C. Positron emission tomography: Human brain function and biochemistry. Science 1985; 228: 779–809
- Palacios J. M., Probst A., CortÉS R. Mapping receptors in the human brain. Trends Neurosci. 1986; 9: 284–289
- Coyle J. T., Price D. L., Delong M. R. Alzheimer's disease: A disorder of cortical cholinergic innervation. Science 1983; 219: 1184–1190
- Probst A., Palacios J. M., CortÉS R. Changes in neurotransmitter receptor binding in the hippocampal formation of patients dying with senile dementia of the Alzheimer type: A quantitative autoradiographic study. Soc. Neurosci 1984; 10(Part 2)889, Abstr.
- Probst A., CortÉS R., Ulrich J., Palacios J. M. Differential modification of neurotransmitter receptors in the hippocampus of Alzheimer's disease patients: An autoradiographic study, submitted
- Palacios J. M. Autoradiographic localization of muscarinic cholinergic receptors in the hippocampus of patients with senile dementia. Brain Res. 1982; 243: 173–175
- Perry E. K., Perry R. H. The cholinergic system in Alzheimer's disease. Biochemistry of Dementia, P. J. Roberts. John Wiley, Chichester 1980; 135–183
- Geddes J. W., Monaghan D. T., Cotman C. W., Lott I. T., Kim R. C., Chui H. C. Plasticity of hippocampal circuitry in Alzheimer's disease. Science 1985; 230: 1179–1181
- Penney J. B., Young A. B. Quantitative autoradio-graphy of neurotransmitter receptors in Huntington's disease. Neurol. 1982; 32: 1391–1395
- Walker F. O., Young A. B., Penney J. B., Dovorini-Zis K., Shoulson I. Benzodiazepine and GABA receptors in early Huntington's disease. Neurol. 1984; 34: 1237–1240
- CortÉS R., Probst A., Pazos A., Palacios J. M. Neurotransmitter receptors in the human visual pathway: Effects of unilateral lesions of the optic nerve. Neurosci. Lett. 1985; 22(Suppl.)S319
- Szentagothai J. Glomerular synapses, complex synaptic arrangements, and their operational significance. The Neurosciences: Second Study Program, F. O. Schmitt. Rockefeller, New York 1970; 427–443
- Hendrickson A. E., Ogren M. P., Won J. E., Barber R. P., Wu J. Y. Light and electron microscopic immunocy to-chemical localization of glutamic acid decarboxylase in monkey geniculate complex: Evidence for GABAergic neurons and synapses. J. Neurosci. 1983; 3: 1245–1262
- Dolabela De Lima A., Montero V. M., Singer W. The cholinergic innervation of the visual thalamus: An EM immunocy tochemical study, Exp. Brain Res. 1985; 59: 206–212
- Hubel D. H., Wiesel T. N., Stryker M. P. Anatomical demonstration of orientation columns in macaque monkey. J. Comp. Neurol. 1978; 177: 361–379
- CortÉS R., Pazos A., Probst A., Palacios J. M. Autoradiographic study of the distribution of high affinity H-imipramine binding sites in the human brain, submitted
- Kinnier W. J., Chuang D.-M., Costa E. Down regulation of dihydroalprenolol and imipramine binding sites in brain of rats repeatedly treated with imipramine, Eur. J. Pharmacol. 1980; 67: 289–294
- Quirion R. Interactions between neurotensin and dopamine in the brain: An overview. Peptides 1983; 4: 609–615
- Palacios J. M., Kuhar M. J. Neurotensin receptors are located on dopamine-containing neurons in rat midbrain. Nature 1981; 294: 273–285
- Uhl G. R., Whitehouse P. J., Price D. L., Tourtelotte W. W., Kuhar M. J. Parkinson's disease: Depletion of substantia nigra neurotensin receptors. Brain Res. 1984; 308: 186–190
- Sadoul J. L., Checler F., Kitabgi P., Rostene W., Javoy-Agid F., Vincent J. P. Loss of high-affinity neurotensin receptors in substantia nigra from parkinsonian subjects, Biochem. Biophys. Res. Comm. 1984; 125: 395–404
- Uhl G. R., Kuhar M. J. Chronic neuroleptic treatment enhances neurotensin receptor binding in human and rat substantia nigra. Nature 1984; 309: 350–353